JW PharmaceuticalJW중외제약
001060 · KOSPI · ₩001060 · JW중외제약
- Market cap
- ₩570B
- Enterprise value
- ₩565B
- P/E
- 5.6×
- P/B
- 1.4×
- Dividend yield
- 2.8%
- ROE
- 24.7%
- Net margin
- 12.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−40.9% from the high
₩21,550Today: ₩23,200 – ₩23,650₩39,250
Returns
- 1W−7.0%
- 1M−13.4%
- 3M+5.5%
- 6M−27.7%
- YTD−9.0%
- 1Y−1.3%
- Volume today
- 41,883
- 1.2× the 20-day average
- Traded today
- ₩975M
- Listed shares
- 24,581,534
- EPS (12 months)
- ₩4,120
- Earnings yield 17.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 45 of 100 (50 is a normal day for this stock).
- MomentumWeak-13.6% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
JW Pharmaceutical stock overview
JW Pharmaceutical (JW중외제약, KRX: 001060) is listed on KOSPI, in the Biotech & Pharma sector. Its shares closed at ₩23,200 on Oct 28, 2026, up 0.22% on the day, giving it a market value of ₩570B.
Key facts
- Market cap
- ₩570B
- Sector
- Biotech & Pharma
- Latest price change
- +0.22%
- As of
- Oct 28, 2026
Quick answers about JW Pharmaceutical
- What is the market cap of JW Pharmaceutical?
- The market capitalisation of JW Pharmaceutical was ₩570B at the close on Oct 28, 2026.
- Who are the largest shareholders of JW Pharmaceutical?
- According to the latest official filings, the largest reported holders are JW Holdings (45.89%, as of Sep 17, 2026); National Pension Service (2.44%, as of Dec 31, 2025); VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND (0.79%, as of Jul 31, 2026).
- When is the next earnings report from JW Pharmaceutical?
- Korean companies rarely announce results dates in advance. Based on when JW Pharmaceutical filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own JW Pharmaceutical?
- Yes. The National Pension Service held 2.44% of JW Pharmaceutical shares as of Dec 31, 2025.
Company profile
Loading data for this company — check back soon
- Korean name
- JW중외제약
- Sector
- Biotech & Pharma
- CEO
- 대표이사 신영섭, 함은경(각자 대표이사)
- Founded
- Aug 1945
- Listed
- Jun 1976
- Listed shares
- 24,581,534
- Fiscal year ends
- Month 12
- Website
- www.jw-pharma.co.kr
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- [Amended] Imposition of FinesOct 8, 2026
- Acquisition of shares in another companySep 29, 2026
- [Amended] Imposition of FinesSep 18, 2026
- Change in largest shareholder's holdingsSep 17, 2026
- 5%+ holding reportSep 17, 2026
Titles in Korean until English translations are added.
Also known as: JW Pharmaceutical / JW중외제약 / 001060 / KRX:001060
Source: KRX statistical information